Endocrine Update 2021 - LIVESTREAM

Memo

Designed for endocrinologists and interested internists and surgeons, this course addresses gaps in medical knowledge and barriers in clinical practice to improve the outcomes of patients with endocrine and metabolic disorders. This program will consist of lecture, small group, panel discussion formats covering best practices, barriers to optimal patient outcomes and new approaches to the evaluation and management of complex and common endocrine disorders. Topics include SGLT 2 inhibitors; indications for immune checkpoint inhibitors in cancer therapies; treatment strategies for checkpoint-induced endocrinopathies; genomics of medullary thyroid cancer; current and recently approved systemic treatment options for patients with advanced medullary thyroid cancer; treatment strategies for patients with MTC; and management of bone loss after bariatric surgery to prevent metabolic bone disease. COURSE HIGHLIGHTS• Updates on best practices and new approaches to the evaluation and management of complex and common endocrine disorders• Interactive case-based presentations with dedicated time for questions and discussion with faculty and colleagues• Practical information that can be applied immediately to the clinical practice• Access to course recordings for one year On Monday March 01, 2021 at 8:00 am (ends Friday March 05, 2021 at 12:30 pm) Prices: M.D., D.O., Ph.D Registration: USD 750.00,Allied Health, NP, PA, Retiree Registration: USD 675.00